MongoDB director reports 31,000-share sale; holdings remain over 1.6M shares
Rhea-AI Filing Summary
Dwight A. Merriman, a MongoDB, Inc. (MDB) director, reported multiple sales of Class A common stock on 09/19/2025 executed under a Rule 10b5-1 trading plan. The Form 4 discloses seven sale entries totaling 31,000 shares sold at weighted-average prices ranging roughly from $318.08 to $322.84 across the separate transactions. After the reported transactions, the filing shows 1,079,316 shares beneficially owned directly by the reporting person, 514,896 shares held indirectly by a trust for his children, and 83,845 shares held by the Dwight A. Merriman Charitable Foundation (over which he has voting and investment power but no pecuniary interest).
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating preplanned, compliant insider sales.
- Detailed disclosure of weighted-average prices and the nature of indirect holdings (trust and charitable foundation).
- Significant remaining holdings disclosed: 1,079,316 shares direct, 514,896 held by trust, and 83,845 held by the charitable foundation.
Negative
- Insider disposed of 31,000 Class A shares on 09/19/2025, which reduces direct economic exposure.
- Sales spanned price ranges from about $318.08 to $322.84, implying multiple executions rather than a single-block sale.
Insights
TL;DR Insider sold 31,000 MDB shares under a 10b5-1 plan; holdings remain sizable with both direct and indirect ownership.
The reported sale of 31,000 Class A shares on 09/19/2025 was executed pursuant to an established Rule 10b5-1 trading plan, with weighted-average prices reported in the filing and per-footnote ranges between approximately $318.08 and $322.84. The reporting person retains substantial ownership: 1,079,316 shares directly and additional indirect holdings through a trust (514,896) and a charitable foundation (83,845). For investors, this is a transparent disclosure of scheduled insider liquidity rather than an unscheduled disposition; the filing does not present any additional financial metrics or company guidance.
TL;DR Sales were made under a documented 10b5-1 plan and were properly disclosed on Form 4, preserving compliance norms.
The Form 4 indicates the transactions were covered by a 10b5-1 plan, which provides an affirmative defense to insider trading allegations when conditions are met. The filing includes granular footnotes about weighted-average prices and the nature of indirect holdings (trust for children and charitable foundation). The signature by an attorney-in-fact is dated 09/23/2025, completing the required disclosure formalities. No amendments or indications of unscheduled or suspicious trades are stated in the document.